~4 spots leftby Jul 2025

Oxygen Gas for Inhalation for Respiratory Insufficiency

Recruiting in Palo Alto (17 mi)
AD
Overseen byAnthony Doufas, MD, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Stanford University
Must not be taking: Opioids
Disqualifiers: COPD, Neurological, Cardiopulmonary, Psychiatric, others
No Placebo Group
Approved in 3 Jurisdictions

Trial Summary

What is the purpose of this trial?

In this randomized-controlled trial the investigators will examine the effect of oxygen supplementation on the recovery of breathing for 90 minutes in the immediate post-anesthesia period starting from extubation of the trachea.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you have a chronic pain condition treated with opioids, you would not be eligible to participate.

What data supports the effectiveness of the treatment Oxygen Gas for Inhalation for Respiratory Insufficiency?

The research indicates that oxygen therapy is essential for treating respiratory insufficiency when there is a significant lack of oxygen in the blood (hypoxemia), especially when levels are critically low. It is most effective when used in controlled and dosed amounts for patients with severe respiratory issues.12345

Is oxygen gas safe for inhalation in humans?

The research articles primarily discuss nitrous oxide mixed with oxygen, which is generally considered safe for use in various medical settings, with no major adverse effects reported. However, these studies do not specifically address the safety of pure oxygen gas for inhalation.678910

How is the treatment 'Oxygen Gas for Inhalation' unique for respiratory insufficiency?

Oxygen Gas for Inhalation is unique because it provides controlled, continuous oxygen through a nasopharyngeal catheter, which helps improve oxygen levels and overall respiratory function without the risk of worsening respiratory depression. This method allows for safe home use, unlike some other treatments that may require hospital settings.3491112

Research Team

AD

Anthony Doufas, MD, PhD

Principal Investigator

Professor, Department of Anesthesiology, Stanford University Medical School

Eligibility Criteria

This trial is for adults in good to moderate health (ASA I-III), with a BMI under 40, who are scheduled for robotic-assisted kidney removal surgery. It's not open to those with chronic lung disease, severe brain/heart/lung conditions, major psychiatric or untreated thyroid issues, chronic pain on opioid treatment, low blood count or significant blood loss during surgery.

Inclusion Criteria

American Society of Anesthesiologists (ASA) physical status I-III
Your body mass index (BMI) is below 40 kg/m2.
You are planning to have a type of kidney surgery called robotic-assisted radical laparoscopic nephrectomy.

Exclusion Criteria

You have been diagnosed with severe COPD, neurological, cardiopulmonary, or psychiatric conditions, or untreated thyroid disorder.
You are currently taking prescription painkillers for a long-term pain problem.
Patients with a hematocrit lower than 30% at the end of surgery, or those with an excessive blood loss, requiring transfusion of blood products during surgery

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either conservative or liberal oxygen supplementation during the 90-minute post-anesthesia period

90 minutes
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Oxygen Gas for Inhalation (Gas)
Trial OverviewThe study tests if breathing high levels of oxygen after general anesthesia helps patients recover their normal breathing faster. Participants will be randomly assigned to receive extra oxygen or not after they wake up from anesthesia and will be monitored for 90 minutes.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: "Liberal O2 Supplementation"Experimental Treatment1 Intervention
Oxygen administration will be titrated to an SpO2 \> 96%.
Group II: "Conservative O2 Supplementation"Active Control1 Intervention
Oxygen administration will be titrated to a oxyhemoglobin saturation (SpO2) between 90 and 94%.

Oxygen Gas for Inhalation is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as Oxygen for:
  • Anoxia
  • Hypoxia
  • Dyspnea
  • Respiratory distress
  • Post-anesthesia recovery

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+
Dr. Richard A. Miller profile image

Dr. Richard A. Miller

Stanford University

Chief Executive Officer since 2023

Stanford University, MD

Dr. Robert Schott profile image

Dr. Robert Schott

Stanford University

Chief Medical Officer since 2021

University of Michigan, MD

Findings from Research

Inhaled nitric oxide (iNO) significantly improved oxygen levels in patients with severe hypoxemia, with arterial oxygen partial pressure (PaO2) increasing from 60.7 to 72.3 mm Hg after treatment (P=.008).
The use of iNO allowed for safe transport of patients to a tertiary care center, with 60.2% of those treated surviving to discharge, compared to a 50% survival rate in patients transported without iNO.
Inhaled nitric oxide to improve oxygenation for safe critical care transport of adults with severe hypoxemia.Teman, NR., Thomas, J., Bryner, BS., et al.[2020]
Inhaled nitric oxide (iNO) therapy is more effective in ARDS patients with a greater amount of normal lung tissue surrounding small consolidated areas, as indicated by a significant correlation between the morphology of lung injury and the response to iNO.
Patients who did not respond to iNO therapy had larger, more coherently consolidated lung regions, suggesting that the distribution of lung injury plays a crucial role in the efficacy of iNO treatment.
[Computed tomographic criteria as expected effect to inhaled nitric oxide in patients with severe acute respiratory distress syndrome].Röttgen, R., Busch, T., Lohbrunner, H., et al.[2020]
Inhaled nitric oxide (INO) was used in a study of 163 children in the pediatric ICU, showing that early preterm infants (born <32 weeks) had better outcomes, including more ventilator-free days and lower mortality rates compared to late preterm and full-term infants.
The study suggests that INO was initiated for less severe lung disease in early preterm infants, indicating a need for future clinical trials to standardize criteria for starting INO therapy and to consider the history of prematurity when evaluating its effectiveness.
Inhaled Nitric Oxide Use and Outcomes in Critically Ill Children With a History of Prematurity.Maddux, AB., Mourani, PM., Banks, R., et al.[2023]

References

Inhaled nitric oxide to improve oxygenation for safe critical care transport of adults with severe hypoxemia. [2020]
[Computed tomographic criteria as expected effect to inhaled nitric oxide in patients with severe acute respiratory distress syndrome]. [2020]
Inhaled Nitric Oxide Use and Outcomes in Critically Ill Children With a History of Prematurity. [2023]
A quality improvement project improving the value of iNO utilization in preterm and term infants. [2021]
[Indications and contraindications for oxygen therapy of respiratory insufficiency]. [2009]
Prehospital pharmacology: nitrous oxide. [2017]
Use of Entonox in the community for control of procedural pain. [2019]
[Premixed 50% nitrous oxide and oxygen: theoretical recalls and practical modalities]. [2017]
Decompression sickness risk at 6553 m breathing two gas mixtures. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Nitrous oxide sedation/analgesia in emergency medicine. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Therapeutic gases for neonatal and pediatric respiratory care. [2016]
[Adaptation to oxygen breathing]. [2013]